ACRO BIOMEDICAL CO., LTD. Quarterly Operating Income (Loss) in USD from Q4 2016 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Acro Biomedical Co., Ltd. quarterly/annual Operating Income (Loss) history and growth rate from Q4 2016 to Q2 2023.
  • Acro Biomedical Co., Ltd. Operating Income (Loss) for the quarter ending June 30, 2023 was -$3.19M, a 20.1% increase year-over-year.
  • Acro Biomedical Co., Ltd. Operating Income (Loss) for the twelve months ending June 30, 2023 was -$15.1M, a 2.54% decline year-over-year.
  • Acro Biomedical Co., Ltd. annual Operating Income (Loss) for 2022 was -$15.9M, a 106% decline from 2021.
  • Acro Biomedical Co., Ltd. annual Operating Income (Loss) for 2021 was -$7.69M, a 5797% decline from 2020.
  • Acro Biomedical Co., Ltd. annual Operating Income (Loss) for 2020 was -$130K, a 69.1% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 -$15.1M -$3.19M +$802K +20.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$15.9M -$4M -$75K -1.91% Jan 1, 2023 Mar 31, 2023 10-Q 2023-08-02
Q4 2022 -$15.9M -$3.93M -$81.3K -2.11% Oct 1, 2022 Dec 31, 2022 10-K 2023-07-21
Q3 2022 -$15.8M -$4.01M -$1.02M -34.1% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-21
Q2 2022 -$14.8M -$4M -$3.2M -404% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$11.6M -$3.93M -$3.87M -6793% Jan 1, 2022 Mar 31, 2022 10-Q 2023-08-02
Q4 2021 -$7.69M -$3.85M -$3.77M -4858% Oct 1, 2021 Dec 31, 2021 10-K 2023-07-21
Q3 2021 -$3.92M -$2.99M -$2.92M -4080% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-21
Q2 2021 -$1M -$793K -$731K -1164% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$269K -$57K -$139K -170% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$130K -$77.7K -$2.28K -3.02% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-15
Q3 2020 -$128K -$71.5K -$7.08K -11% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-22
Q2 2020 -$121K -$62.8K +$5.32K +7.81% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-23
Q1 2020 -$126K $81.6K +$296K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-24
Q4 2019 -$423K -$75.4K +$18.8K +20% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-02
Q3 2019 -$442K -$64.5K -$226K -140% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-17
Q2 2019 -$216K -$68.1K -$244K -139% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-19
Q1 2019 $28.3K -$215K -$313K -319% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-19
Q4 2018 $341K -$94.2K -$174K -217% Oct 1, 2018 Dec 31, 2018 10-K 2021-04-02
Q3 2018 $516K $161K +$122K +308% Jul 1, 2018 Sep 30, 2018 10-KT 2020-03-27
Q2 2018 $394K $176K +$188K Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-14
Q1 2018 $206K $98K +$120K Jan 1, 2018 Mar 31, 2018 10-Q 2018-08-01
Q4 2017 $85.4K $80.2K +$87.6K Oct 1, 2017 Dec 31, 2017 10-Q 2018-02-14
Q3 2017 -$2.25K $39.5K Jul 1, 2017 Sep 30, 2017 10-K 2018-12-28
Q2 2017 -$11.9K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$22.4K Jan 1, 2017 Mar 31, 2017 10-Q 2018-08-01
Q4 2016 -$7.41K Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.